Legend Biotech (NASDAQ:PLRX) Coverage Initiated by Analysts at Piper Sandler
Equities research analysts at Piper Sandler began coverage on shares of Legend Biotech (NASDAQ:PLRX) in a note issued to investors on Monday, MarketBeat Ratings reports. The brokerage set an “overweight” rating and a $50.00 price target on the stock. Piper Sandler’s price target would indicate a potential upside of 54.04% from the stock’s previous close.
Shares of NASDAQ:PLRX opened at $32.46 on Monday. Legend Biotech has a 12 month low of $21.05 and a 12 month high of $35.63.
Legend Biotech Company Profile
See Also: What is the FTSE 100 index?
Receive News & Ratings for Legend Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Legend Biotech and related companies with MarketBeat.com's FREE daily email newsletter.